Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer.
Dal Pra A, Dirix P, Khoo V, Carrie C, Cozzarini C, Fonteyne V, Ghadjar P, Gomez-Iturriaga A, Panebianco V, Zapatero A, Bossi A, Wiegel T. Dal Pra A, et al. Among authors: gomez iturriaga a. Clin Transl Radiat Oncol. 2023 May 9;41:100638. doi: 10.1016/j.ctro.2023.100638. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37251620 Free PMC article. Review.
High-dose-rate brachytherapy in lower eyelid cancer.
Martínez-Monge R, Gómez-Iturriaga A. Martínez-Monge R, et al. Brachytherapy. 2007 Jul-Sep;6(3):227-9. doi: 10.1016/j.brachy.2007.03.004. Brachytherapy. 2007. PMID: 17681245
Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.
Gomez-Iturriaga A, Cacicedo J, Navarro A, Morillo V, Willisch P, Carvajal C, Hortelano E, Lopez-Guerra JL, Illescas A, Casquero F, Del Hoyo O, Ciervide R, Irasarri A, Pijoan JI, Bilbao P. Gomez-Iturriaga A, et al. BMC Palliat Care. 2015 Oct 1;14:48. doi: 10.1186/s12904-015-0045-8. BMC Palliat Care. 2015. PMID: 26427616 Free PMC article.
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):259-72. doi: 10.1016/j.rpor.2015.04.003. Epub 2015 May 30. Rep Pract Oncol Radiother. 2015. PMID: 26109913 Free PMC article. Review.
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):90-2. doi: 10.1016/j.rpor.2015.06.006. Epub 2015 Jul 20. Rep Pract Oncol Radiother. 2016. PMID: 26900365 Free PMC article.
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer.
Gomez-Iturriaga A, Casquero F, Pijoan JI, Crook J, Urresola A, Ezquerro A, Villeirs GM, Bossi A, Cacicedo J, Buchser D, Bilbao P. Gomez-Iturriaga A, et al. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1172-1178. doi: 10.1016/j.ijrobp.2018.04.039. Epub 2018 Apr 22. Int J Radiat Oncol Biol Phys. 2018. PMID: 29861199
Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.
Gómez-Caamaño A, González-San Segundo C, Henríquez I, Maldonado X, Zapatero A; Expert Panel for the Consensus on Management of Castration-Resistant Prostate Cancer 2017, Urological Tumours Working Group (URONCOR), Spanish Society of Radiation Oncology (SEOR). Gómez-Caamaño A, et al. Clin Transl Oncol. 2019 Apr;21(4):420-432. doi: 10.1007/s12094-018-1940-2. Epub 2018 Oct 6. Clin Transl Oncol. 2019. PMID: 30293231
67 results